GLP-1 Agonists for Diabetes & Weight Loss

What are GLP-1 Agonists?

GLP-1 receptor agonists (also called GLP-1 RAs or incretin mimetics) are a class of medications that mimic the naturally occurring hormone glucagon-like peptide-1. When you eat, your gut releases GLP-1, which signals your pancreas to produce insulin. GLP-1 medications amplify this effect and provide additional benefits:

• Enhanced insulin secretion — Only when blood sugar is elevated, minimizing hypoglycemia risk
• Reduced glucagon release — Prevents your liver from dumping excess sugar into your blood
• Slowed gastric emptying — Food stays in your stomach longer, helping you feel full
• Appetite suppression — Acts on brain receptors to reduce hunger and cravings
• Cardiovascular protection — Several GLP-1 medications reduce heart attack and stroke risk

The result: better blood sugar control, significant weight loss, and reduced cardiovascular risk — making GLP-1 medications some of the most impactful advances in diabetes and obesity treatment in decades.

Available GLP-1 Medications

There are currently several FDA-approved GLP-1 receptor agonists on the market. Some are approved only for type 2 diabetes, while others have additional approvals for weight management or cardiovascular risk reduction.

Other GLP-1 options include Victoza (liraglutide, daily injection), Saxenda (liraglutide for weight loss), and Byetta/Bydureon (exenatide).

How do GLP-1 medications compare?

*Weight loss formulations (Wegovy, Zepbound) studied in non-diabetic populations. Prices are average cash prices without insurance from GoodRx (February 2026). Individual results and costs vary.

How do GLP-1 agonists work?

GLP-1 medications work through multiple pathways to improve metabolic health:

1. Pancreas: Smart Insulin Release

Unlike older diabetes medications, GLP-1 agonists are "glucose-dependent" — they only stimulate insulin release when blood sugar is actually elevated. This dramatically reduces the risk of hypoglycemia (low blood sugar) compared to sulfonylureas or insulin.

2. Liver: Glucagon Suppression

GLP-1 medications suppress the release of glucagon, the hormone that tells your liver to release stored sugar. This prevents the blood sugar spikes that occur between meals and overnight.

3. Stomach: Delayed Emptying

Food stays in your stomach longer, which slows the absorption of glucose and creates prolonged feelings of fullness. This is why many patients experience reduced appetite and eat smaller portions naturally.

4. Brain: Appetite Control

GLP-1 receptors in the hypothalamus are involved in satiety signaling. GLP-1 medications act on these receptors to reduce hunger, decrease food cravings, and change food preferences (many patients report reduced desire for high-fat and high-sugar foods).

What do the clinical trials show?

GLP-1 medications have been extensively studied in large clinical trials. Here are the key findings:

SUSTAIN Trials (Semaglutide/Ozempic)

Over 8,000 patients studied. Key findings: 1.5% A1C reduction at 2 mg dose, 26% reduction in major cardiovascular events (SUSTAIN 6), average weight loss of 12-14 pounds.

STEP Trials (Semaglutide/Wegovy)

Over 4,500 patients with obesity (without diabetes). Key findings: 15-17% body weight loss at 68 weeks, with one-third of patients losing over 20% of their body weight.

SELECT Trial (Semaglutide CV Outcomes)

17,604 patients with obesity and cardiovascular disease but without diabetes. Landmark finding: 20% reduction in heart attack, stroke, and cardiovascular death — the first weight loss medication to demonstrate cardiovascular benefit.

SURMOUNT Trials (Tirzepatide/Mounjaro/Zepbound)

Over 5,000 patients studied. Key findings: Up to 22.5% body weight loss at highest dose, with over 60% of patients losing at least 20% of their weight. A1C reductions of 2.0-2.5%, the highest in the class.

Ongoing research: Clinical trials are investigating GLP-1 medications for sleep apnea, fatty liver disease (NASH/MASH), heart failure with preserved ejection fraction, kidney disease, and even Alzheimer's disease.

Who qualifies for GLP-1 medications?

GLP-1 medications are FDA-approved for specific conditions. Your eligibility depends on which medication and which indication:

For Type 2 Diabetes (Ozempic, Mounjaro, Trulicity, etc.)

• Adults diagnosed with type 2 diabetes mellitus
• Used as an adjunct to diet and exercise
• May be used alone or with other diabetes medications
• Not recommended as first-line therapy (metformin usually tried first)

For Weight Loss (Wegovy, Zepbound)

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 with at least one weight-related condition:
  • Type 2 diabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea
  • Cardiovascular disease
• Adolescents 12+ with BMI at 95th percentile or higher (Wegovy only)

Common and serious side effects

GLP-1 medications share a similar side effect profile, primarily gastrointestinal. Most side effects improve over time as your body adjusts.

Common Side Effects (may affect 10-40% of patients)

• Nausea — Most common, especially during dose escalation. Usually improves after 4-8 weeks.
• Vomiting — More common with tirzepatide; tends to decrease over time.
• Diarrhea — May occur early in treatment.
• Constipation — Can be managed with fiber and hydration.
• Abdominal pain — Usually mild; report severe pain to your doctor.
• Injection site reactions — Redness, swelling, or itching at injection site.

Serious Side Effects (rare but important)

• Pancreatitis — Stop medication and seek care for severe abdominal pain radiating to back.
• Gallbladder disease — Rapid weight loss increases gallstone risk.
• Kidney injury — Usually related to dehydration from GI symptoms.
• Diabetic retinopathy complications — Rare; more common with rapid blood sugar improvement.
• Hypoglycemia — Risk increases when combined with insulin or sulfonylureas.
• Thyroid tumors — Observed in rodents; not confirmed in humans. Still contraindicated in MTC/MEN2.

How much do GLP-1 medications cost?

GLP-1 medications are expensive without insurance coverage. Here's what you need to know:

Cash Prices (without insurance)

• Ozempic: $900-$1,000/month
• Wegovy: $1,300-$1,400/month
• Mounjaro: $1,000-$1,100/month
• Zepbound: $1,000-$1,100/month
• Trulicity: $900-$1,000/month

Insurance Coverage

For diabetes: Most commercial insurance plans cover GLP-1 medications with prior authorization. Copays typically range from $25-$300 depending on your plan's formulary tier.

For weight loss: Coverage is more limited. Many plans explicitly exclude "weight loss drugs." Check if your plan covers Wegovy or Zepbound for obesity. Some employers are adding coverage due to demonstrated health benefits.

Medicare: Part D covers GLP-1 medications for diabetes but generally excludes weight loss indications. This may change as policy evolves.

Savings Programs

• Manufacturer savings cards: Novo Nordisk and Eli Lilly offer programs that can reduce copays to $0-$25 for eligible commercially insured patients.
• Patient assistance programs: For uninsured or underinsured patients who meet income requirements.
• Compounded semaglutide: Some pharmacies offer compounded versions at lower cost, though quality and safety vary. The FDA has issued warnings about some compounders.

What should I discuss with my doctor?

GLP-1 medications are prescription medications that require medical supervision. Before starting, discuss:

• Your complete medical history, especially thyroid cancer, pancreatitis, kidney disease, or diabetic retinopathy
• All medications you're taking, particularly insulin or sulfonylureas (increased hypoglycemia risk)
• Whether you're pregnant, planning pregnancy, or breastfeeding (stop 2 months before conception)
• Your insurance coverage and savings program eligibility
• Realistic expectations — these medications work best with lifestyle changes
• Long-term plans — weight tends to return if medication is stopped

This is not medical advice. Only your healthcare provider can determine if a GLP-1 medication is appropriate for you.

Last reviewed: February 2026 by the thrive.md Clinical Advisory Team

Related Medications & Conditions

GLP-1 medications are used for multiple conditions. These related topics can help you understand the full picture.